Patent ID: 11965028
Assignee: THERANOVIR
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The antibody or antibody fragment of claim 1 comprising the following CDRs:
CDR-H1: SFGMH (SEQ ID NO: 7),
CDR-H2: YISSGSSTIYYADTVKG (SEQ ID NO:35),
CDR-H3: RHYGRSRYWYFDV (SEQ ID NO: 36),
CDR-L1: KASQDIKSYLS (SEQ ID NO:10),
CDR-L2: YATSLAD (SEQ ID NO:38), and
CDR-L3: LQYGESPYT (SEQ ID NO:12).